Dysregulation of the NLRP3 inflammasome complex and related cytokines in patients with multiple myeloma. (Q53630999)

16 May 2018

title

Dysregulation of the NLRP3 inflammasome complex and related cytokines in patients with multiple myeloma. (English)

1 reference

16 May 2018

1 reference

Yanjie Li

1

1 reference

16 May 2018

Ning Li

2

1 reference

16 May 2018

Zhiling Yan

3

1 reference

16 May 2018

Hujun Li

4

1 reference

16 May 2018

Lili Chen

5

1 reference

16 May 2018

Zhiyao Zhang

6

1 reference

16 May 2018

Guoqin Fan

7

1 reference

16 May 2018

Kailin Xu

8

1 reference

16 May 2018

Zhenyu Li

9

1 reference

16 May 2018

publication date

6 July 2015

1 reference

16 May 2018

published in

Hematology

1 reference

16 May 2018

volume

21

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

144-151

1 reference

16 May 2018

Bone marrow microenvironment in multiple myeloma progression.

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Multiple myeloma: biology of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

NALPs: a novel protein family involved in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Inflammasome recognition of influenza virus is essential for adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

International staging system for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

International uniform response criteria for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Critical regulation of early Th17 cell differentiation by interleukin-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

A functional role for Nlrp6 in intestinal inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Inflammasomes and host defenses against bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

IL-1, IL-18, and IL-33 families of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Innate instruction of adaptive immunity revisited: the inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1a) in human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Involvement of the NLRP3 Inflammasome in Innate and Humoral Adaptive Immune Responses to Fungal -Glucan

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845415Y.0000000029

10.1179/1607845415Y.0000000029

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

26146985

1 reference

16 May 2018